申请人:Hoffmann-La Roche Inc.
公开号:US09255110B2
公开(公告)日:2016-02-09
Compounds of the formula I or II:
wherein X, m, Ar, R1 and R2 are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.
式I或II的化合物:
其中X,m,Ar,R1和R2的定义如本文所述。该化合物对于治疗IRAK介导的疾病是有用的。